Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ablett

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
British Journal of Cancer|August 2, 2006
A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumoursS Lowis, I Lewis, A Elsworth, et al.
British Journal of Cancer|January 5, 2001
A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group InvestigationE J Estlin, C R Pinkerton, I J Lewis, et al.
British Journal of Cancer|September 23, 1998
Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study GroupE J Estlin, L Lashford, S Ablett, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
British Journal of Cancer|August 2, 2006
A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumoursS Lowis, I Lewis, A Elsworth, et al.
British Journal of Cancer|January 5, 2001
A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group InvestigationE J Estlin, C R Pinkerton, I J Lewis, et al.
British Journal of Cancer|September 23, 1998
Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study GroupE J Estlin, L Lashford, S Ablett, et al.
Pageof 2